Eli Lilly Stock: Is LLY Outperforming the Healthcare Sector?

Eli Lilly and Company (LLY), headquartered in Indianapolis, Indiana, is renowned as one of the largest pharmaceutical companies with a diversified product profile. Valued at $790.51 billion by market cap, the company discovers, develops, and markets human pharmaceuticals worldwide by harnessing the power of biotechnology, chemistry, and genetic medicine, helping address diseases like diabetes, cancer, obesity, and Alzheimer’s.

Companies worth $200 billion or more are generally described as “mega-cap stocks,” LLY fits that description, reflecting its substantial size, stability, and influence in the pharma industry. LLY is the highest-ranked pharmaceutical company by market cap in the S&P 500 Index ($SPX).